SEC Form 5 · accession 0000899243-17-004071
Global Blood Therapeutics, Inc. · GBT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jung Choi
Officer — See Remarks
Period of report
Dec 31, 2016
Accepted (ET)
Feb 14, 2017 · 7:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001629137
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 31, 2016 | A | 591 | $15.20 | A | 144,197 | D | |
| Common StockF1 | Jan 31, 2017 | A | 658 | $13.73 | A | 144,855 | D | |
| Common Stock | holding | — | — | — | 25,000 | I | Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Remarks
Chief Business and Strategy Officer